跳至: [中文]   [数字0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] 请输入前几个字:

显示项目3576-3600 / 12927. (共518页) << < 139 140 141 142 143 144 145 146 147 148 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2024-06-24	Discovery of dual MER/AXL kinase inhibitors as bifunctional small molecules for inhibiting tumor growth and enhancing tumor immune microenvironment	Journal of Medicinal Chemistry. 2024 Jun 24;Article in Press.
2005-05	Discovery of genetic difference between asthmatic children with high IgE level and normal IgE level by whole genome linkage disequilibrium mapping using 763 autosomal STR markers	Journal of Human Genetics. 2005 May;50(5):249-258.
2020-08-20	Discovery of M protease inhibitors encoded by SARS-CoV-2	Antimicrobial Agents and Chemotherapy. 2020 Aug 20;64(9):e00872-20.
2014-11	Discovery of multiple kinases inhibitors, DBPR114, as the novel anti-cancer agent	European Journal of Cancer. 2014 Nov;50(Suppl. 6):92-93.
2010-12	Discovery of non-glycoside sodium-dependent glucose Co-transporter 2 (SGLT2) inhibitors by ligand-based virtual screening	Journal of Medicinal Chemistry. 2010 Dec;53(24):8770-8774.
2023-10	Discovery of novel AXL and MER inhibitors as potential anticancer and immune modulator drugs	Annals of Oncology. 2023 Oct;34(Suppl. 2):S214.
2016-11-29	Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design	European Journal of Medicinal Chemistry. 2016 Nov 29;124:186-199.
2011-01-13	Discovery of novel N -Beta- d -Xylosylindole derivatives as sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the management of hyperglycemia in diabetes	Journal of Medicinal Chemistry. 2011 Jan 13;54(1):166-178.
2012-02	Discovery of novel stem cell mobilizers that target the CXCR4 receptor	ChemMedChem. 2012 Feb;7(2):209-212.
2022-03-02	Discovery of potential neuroprotective agents against paclitaxel-induced peripheral neuropathy	Journal of Medicinal Chemistry. 2022 Mar 2;65(6):4767-4782.
2014-08	Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells	Oncotarget. 2014 Aug;5(15):6087-6101.
2020-04	Discovery of survival predictor and early monitoring biomarkers for EGFR tyrosine kinase inhibitor therapy in lung adenocarcinoma by integrative omics analysis	FASEB Journal. 2020 Apr;34(S1):Abstract number 08868.
2023-10-05	Discovery of tetrasubstituted thiophenes as Cisd2 activators: A potential novel therapeutic option in nonalcoholic fatty liver disease	European Journal of Medicinal Chemistry. 2023 Oct 05;258:Article number 115583.
2014-09	Discovery, structure-activity relationship studies, and anti-nociceptive effects of 1-phenyl-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one as novel opioid receptor agonists	Bioorganic and Medicinal Chemistry. 2014 Sep;22(17): 4694-4703.
2017-01	Discovery, structure-activity relationship studies, and anti-nociceptive effects of N-(1,2,3,4-tetrahydro-1-isoquinolinylmethyl)benzamides as novel opioid receptor agonists	European Journal of Medicinal Chemistry. 2017 Jan;126:202-217.
2023-01-11	Discrepant activation pattern of inflammation and pyroptosis induced in dermal fibroblasts in response to dengue virus serotypes 1 and 2 and nonstructural protein 1	Microbiology Spectrum. 2023 Jan;11(1):Article number e0358622.
2016-04-21	The discrete random-effects model-assessing benefit and consistency of treatment effect	Multiregional Clinical Trials for Simultaneous Global New Drug Development. 2016 Apr 21:245-258.
2021-05	Discriminating subcortical ischemic vascular disease and Alzheimer's disease by diffusion kurtosis imaging in segregated thalamic regions	Human Brain Mapping. 2021 May;42(7):2018-2031.
2022-05-16	Discrimination of methicillin-resistant staphylococcus aureus by MALDI-TOF mass spectrometry with machine learning techniques in patients with staphylococcus aureus bacteremia	Pathogens. 2022 May 16;11(5):Article number 586.
2014-11	Disease activity affects all domains of quality of life in patients with rheumatoid arthritis and is modified by disease duration	Clinical and Experimental Rheumatology. 2014 Nov-Dec ;32(6):898-903.
2015-01	Disease activity affects all domains of quality of life in patients with rheumatoid arthritis and is modified by disease duration.[Erratum: Clinical and Experimental Rheumatology. 2014 Nov-Dec ;32(6):898-903.]	Clinical and Experimental Rheumatology. 2015 Jan;33(1):135.
2022-11	Disease burden and demographic characteristics of mucormycosis: A nationwide population-based study in Taiwan, 2006-2017	Mycoses. 2022 Nov;65(11):1001-1009.
2009-02	Disease burden and epidemiological characteristics of varicella in Taiwan from 2000 to 2005	Journal of Microbiology, Immunology and Infection. 2009 Feb;42(1):5-12.
2010-02	Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan	Vaccine. 2010 Feb;28(5):1217-1220
2006-12-15	Disease burden and related medical costs of rotavirus infections in Taiwan	BMC Infectious Diseases. 2006 Dec;6:Article number 176.

显示项目3576-3600 / 12927. (共518页) << < 139 140 141 142 143 144 145 146 147 148 > >> 每页显示[10|25|50]项目